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Abstract: Cancer prevention continues to be a high research priority and the most optimal way 
to ultimately lower the economic and psychological burden of cancer. Many known risk factors 
associated with cancer are related to dietary and lifestyle factors and can be avoided. These risk 
factors include among others, smoking, obesity, alcohol, physical inactivity, and carcinogens in 
diet. This article reviews the biological mechanisms leading to cancer in association with these 
factors, highlights important achievable cancer prevention methods, addresses commonly asked 
questions about lifestyle and cancer, and dispels some of the myths about cancer prevention.
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Introduction
“Prevention” in medicine, refers to an action taken to decrease the chance of getting 
a disease or condition. According to the National Cancer Institute,1 cancer prevention 
involves avoiding risk factors, such as smoking and increasing protective factors that 
may decrease a person’s chance of developing cancer. In general, cancer is caused by 
multiple genetic defects that can result from exposure to environmental, dietary, and 
lifestyle risk factors, as well as infectious agents. The gradual carcinogenetic changes 
in the biological behavior of a susceptible clonogenic population of cells may span 
years or decades. Many of the known risk factors can be potentially avoided. However, 
eliminating potential risk factors by no means guarantees that one will not actually get 
cancer due to the interplay of several insults rendering some people more susceptible 
and genetically predisposed than others. Also cancer is not a single disease but a 
group of related diseases. Nevertheless, learning about and utilizing protective factors 
is an important first step toward cancer prevention. Also, there has been a revived 
interest by federal as well private agencies in promoting cancer prevention and risk 
reduction research and strategies in view of rising health care cost and its burden on the 
economy. Cancer prevention on a large scale would be the optimal way to ultimately 
lower the physical, emotional, and financial burden of cancer as well as improve the 
overall health of cancer survivors by reducing the risk of cancer recurrence and the 
development of second cancers. A review of all possible chemical or biological cancer-
promoting factors is beyond the scope of this review. The purpose of this article is 
to review the biological mechanisms leading to cancer in association with lifestyle 
factors, describe some of the general cancer prevention methods, and address common 
questions about the associations between dietary and lifestyle measures with cancer. 
In addition, this article aims at dispelling some of the myths about cancer prevention. International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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It emphasizes simple practical strategies aimed at reducing 
the risk of developing cancer and avoiding potentially known 
risk factors.
Smoking
Cigarette smoking is the major single cause of death from 
cancer in the United States (US).2–10 Smoking is directly 
responsible for 85% to 90% of lung cancer deaths, 70% 
of deaths from oral and laryngeal cancer, more than 50% 
deaths from esophageal cancer, 40% of deaths from bladder 
and kidney cancer, about 30% of deaths from pancreatic 
cancer, and a significant number of deaths from cancer of 
the stomach and cervix.2–5 Also, the influence of smoking 
on cancer risk is greatly associated with the duration and 
time effect.5 For example, if one stops smoking immediately, 
a progressive decline in the risk of developing lung cancer 
occurs, but it would take 15 to 20 years before the risk is close 
to that of a nonsmoker.6 In the US, effective tobacco control 
efforts have resulted in substantial declines in smoking and 
smoking-related cancer deaths. As an example, nearly 40% 
of reductions in male lung cancer deaths since the early 
1990s have been attributed to smoking declines in the last 
half century.6 Nevertheless, tobacco use still remains the 
single, largest preventable cause of disease and premature 
death in the US and results in nearly half a million premature 
deaths each year, of which nearly one-third are due to cancer.6 
Despite the increased awareness and the fact that many adult 
smokers want to quit, and effective interventions do exist, 
only a small proportion of tobacco users do try treatment.5 
This gap may represent a major national quality-of-care 
problem. Also, another aspect of tobacco use known as 
smokeless tobacco is becoming prevalent and may increase 
in the US.5 Therefore, increased awareness is important to 
understand net population harms related to use of smokeless 
tobacco which should be the focus of more future research. 
Prevention, especially among youth, and cessation are the 
cornerstones of strategies to reduce tobacco use. Tobacco use 
is a critical and chronic problem that requires close attention 
from health care providers, health care organizations, and 
research support organizations.5
The mechanism linked to the carcinogenic effect of 
tobacco is the presence of a large number of identified 
carcinogens in these products. Around 4000 chemicals 
have been identified in cigarette smoke, among which 
more than 60 are established carcinogens.10 The stron-
gest carcinogens are polycyclic aromatic hydrocarbons 
(PAHs),   N-nitrosamines, and aromatic amines. These 
compounds occur in small quantities, typically about 
5 to 200 ng per cigarette. The most prevalent carcinogens 
are aldehydes and other volatile organic compounds such 
as benzene and butadiene. These compounds are found 
in quantities of 10 to 1000 µg per cigarette. In relation to 
human lung cancer, arguably the most important carcinogens 
are PAHs such as benzo[a]pyrene and the tobacco-specific 
nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone 
(also known as nicotine-derived   nitrosaminoketone [NNK]). 
Carcinogens form the link between nicotine addiction and 
lung cancer. Nicotine is not generally considered to be a 
carcinogen, although it can induce tumors under certain 
special conditions such as hyperoxia. Nicotine can also be 
converted into carcinogens such as NNK in the body.10 The 
cigarette is a disastrous nicotine-delivery device, because 
more than 60 carcinogens, including PAHs and NNK, 
accompany nicotine in each puff. Although the dose of each 
carcinogen per cigarette is quite small, the cumulative dose 
in a lifetime of smoking is substantial.
Healthy weight
Obesity and overweight are two terms referring to the 
range of weight that is considered higher than that of the 
normal general population. The body mass index (BMI) 
is the   number by which the range of obesity or overweight 
is   calculated (by dividing the weight of the person by the 
square of their height). An adult who has a BMI between 25 
and 29.9 is considered overweight and one with a BMI of 
30 or higher is considered obese.11 Both of these conditions 
are considered high risk for certain disease conditions and 
health problems, such as high blood pressure, diabetes, 
stroke, and more recently cancer.12–15 The issue of obesity is 
of paramount importance in the US since it is on the rise.11 
It is estimated that more than 40,000 cancer diagnoses each 
year and around 20% of all cancer-related deaths are caused 
by obesity,14,16 including 15% of cancer deaths in men and 
20% in women.14 The continuously rising obesity heralds 
a worrisome trend. Results from the 1999–2000 National 
Health and Nutrition Examination Survey showed that an 
estimated 64% percent of US adults are either overweight 
or obese.11 This reflects an increase of 7.6 percentage points 
since 199411 with around 30% percent of adults age 20 
and older – nearly 59 million people – having a BMI of 
30 or greater, compared with 23% in 1994. More recently, 
  Centers for Disease Control and Prevention figures released 
in 2010 showed that 2.4 million more Americans became 
obese between 2007 and 2009. Therefore, approximately 
one-third of all the US adult population, or 72.5 million 
people, are now obese.10 A rise in cancer because of obesity International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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is therefore expected in the coming years.17 A link between 
obesity and risk of cancer has been reported at several organ 
sites, including colon, breast (in   postmenopausal women), 
endometrium,   esophagus, gallbladder, and pancreas.12,17 The 
American Institute of Cancer research projects there will 
be more than 103,000 new cancer cases caused by excess 
body fat in 2010.17 Forty-nine percent are projected to be 
endometrial cancers, followed by esophageal cancers at 35% 
and pancreatic cancers at 28%. If the current worrisome 
trend is not interrupted, those numbers are anticipated to 
keep increasing over the next several years in response to 
the increased obesity rates each year.17
The underlying mechanisms linking obesity to cancer 
have been based on potential alterations in the metabolism 
of endogenous hormones, including sex steroids, insulin, and 
insulin-like growth factors, which can lead to distortion of 
the normal balance between cell proliferation, differentiation, 
and apoptosis.13 Also high levels of certain cytokines such as 
interleukin-6 and tumor necrosis factor in obese individuals 
can promote carcinogenesis and the proliferation of normal 
cells into malignant cells.1 In breast cancer, both an increased 
risk of developing breast cancer and dying from the disease 
have been described in obese postmenopausal women and 
are believed to be due to increased levels of estrogen in these 
women.18 Before menopause, the ovaries are the primary 
source of estrogen. However, adipose tissues become the 
main source of estrogen after menopause. Estrogen levels 
in postmenopausal women are 50% to 100% higher among 
obese versus normal weight women.18 Estrogen-sensitive 
tissues are therefore exposed to more estrogen stimulation 
in overweight and obese women, leading to a more rapid 
growth of estrogen-responsive breast tumors. The molecular 
basis for estrogen carcinogenesis is still unclear. One 
  proposed mechanism is that excess estrogen exposure leads 
to elevated generation of reactive oxygen species (ROS), for 
example 15-F2t-isoprostane, through estrogen-receptor and/or 
metabolic activation pathways.19–22 These ROS, along with 
ROS from external sources, such as smoking and dietary 
oxidants, may exhaust human antioxidant defense capability, 
leading to oxidative stress.23–27 The recent   prospective 
Shanghai Women’s Health Study, which included 74,942 
Chinese women aged 40 to 70 years, suggested an association 
between levels of ROS (isoprostanes) with breast cancer and 
BMI.19,28 An increased risk of breast cancer was associated 
with elevated urine levels of isoprostanes, mainly observed 
among women with a high BMI, and the association became 
stronger with increasing BMI. Women with a BMI . 28 
had a higher level of isoprostanes whereas weight loss was 
associated with a decreased level of these ROS.19 The study 
also suggested an inverse association with isoprostanes 
  levels among premenopausal women or those with a low 
BMI. This is consistent with the fact that several suggested 
protective factors for breast cancer risk, such as physical 
activity and parity (normal pregnancy), may be associated 
with significantly elevated levels of lipid peroxidation and 
low oxidative stress.29,30 Compared with postmenopausal 
women, isprostanes levels were lower among healthy 
  premenopausal women.19 An important association therefore 
exists between increased oxidative stress, breast cancer, and 
increased BMI mostly in postmenopausal women.
Another potential mechanism linking obesity with an 
increased risk of developing many cancers including breast 
and colon cancer is hyperinsulinemia and insulin resistance, 
mostly via the insulin-like growth factor (IGF) axis.31 IGF-1 
binds and activates both insulin and IGF receptors that are 
expressed on a number of cells including colon cancer cells. 
IGF-1-mediated receptor activation leads to cell growth and 
proliferation, and inhibition of apoptosis.31 Mechanisms by 
which obesity increases risk of other carcinomas are not 
well described. One of the leading mechanisms proposed for 
esophageal and gastric cancers has been increases in gastric 
reflux due to obesity. However, this remains somewhat 
controversial and more research is needed to further examine 
the issue.32
Physical activity and exercise
Physical activity is any bodily movement produced by 
  skeletal muscles that result in the expenditure of energy. It is 
an important component of energy balance. Physical activity 
can improve overall health by controlling weight, high blood 
pressure, and diabetes. In addition, researchers have been 
interested to learn the effect of physical activity on the risk 
of cancer. Nearly 170 observational epidemiological studies 
of cancer risk and physical activity have been conducted at 
different cancer sites.33–35 The evidence of decreased cancer 
risk with physical activity has been found convincing for 
breast and colon cancer, probable for prostate, and possible 
for lung and endometrial cancer.33 Colorectal cancer has 
been among the most extensively studied cancers in relation 
to physical activity.36 Adults who increase their physical 
activity, either in intensity, duration, or frequency, can 
reduce their risk of developing colon cancer by 30% to 40% 
relative to those who are sedentary regardless of BMI, with 
the greatest risk reduction seen among those who are most 
active.36,37 The magnitude of the protective effect appears 
greatest with high-intensity activity, although the optimal International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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levels and duration of exercise are still difficult to determine 
because of differences between studies. It is estimated that 
30 to 60 minutes of moderate to vigorous physical activity 
per day is needed to protect against colon cancer.36
Physical activity may affect colon cancer risk in various 
ways, including reducing the fecal transit time,   accelerating 
the movement of food through the intestine, thereby reducing 
the length of time that the bowel lining is exposed to 
  mutagens, reducing the inflammation and insulin resistance, 
and modifying hormonal metabolism.37,38 Numerous studies 
have looked at the association between physical activity 
and breast cancer, showing that postmenopausal women 
who are physically active have up to an 80% reduction in 
cancer risk.39 The risk reduction could be attributed to a 
lower BMI, or to the alterations in hormone levels. Vigorous 
  physical activity may decrease the exposure of breast tissue to 
  circulating estrogen, potentially decreasing the risk of breast 
cancer.40,41 It is less clear that physical activity reduces the 
risk of   premenopausal breast cancer.38,39
Other cancers have been reported to be reduced by 
exercise and physical activity but results are less   consistent. 
The most active women have a 20% reduced risk of 
  endometrial cancer compared with the least active women, 
according to a meta-analysis of seven cohort studies.42 
Similarly, a meta-analysis found evidence that people who 
participate in higher levels of recreational physical activity 
have a lower risk of lung cancer.43 However, other studies 
looking into physical activity and lung cancer risk have been 
inconsistent.43–47 Some studies have shown a reduced risk 
of pancreatic cancer for people doing moderate amounts 
of physical activity,48,49 but other studies do not show such 
an association.50–52 There is evidence that men who are 
physically active have a reduced risk of prostate cancer.53–56 
Other reports have been less suggestive.57,58 One large cohort 
study showed no association of physical activity with prostate 
cancer risk in white men, although there was a risk reduction 
for black men.58 Physical activity may also decrease the risk 
of pancreatic cancer.59–61 The proposed mechanism includes 
insulin resistance as an etiologic factor in the development 
of pancreatic neoplasms.60
Diet
The importance of diet as a major cause of cancer has been 
suggested repeatedly.63–80 Dietary patterns, foods, nutrients, 
and other dietary constituents are thought to be closely asso-
ciated with the risk for several types of cancer and as much 
as 40% of cancers are potentially attributable to dietary fac-
tors.65 Dietary factors account for about 30% of all   cancers in 
Western countries and approximately up to 20% in developing 
countries. Diet is considered second only to tobacco as a 
preventable cancer cause.67 It has been estimated that 30% to 
40% of all kinds of cancers can be prevented with a healthy 
lifestyle and simple dietary measures.63,66 While it is not 
yet possible to provide quantitative estimates of the overall 
risks, the research generated from past dietary programs has 
advanced our understanding of broad scale interventions 
which include messages such as simply the use of five fruits 
and vegetables a day. More research is needed, however, to 
identify the determinants of dietary behavior, the interaction 
of dietary behavior, weight control, and physical activity, 
more targeted diet-related interventions, and new methods 
of dietary assessment for tracking the impact of interventions 
and developing effective behavioral interventions.69
As noted earlier, studies conducted over the years have 
suggested a strong correlation between diet and cancer. 
A comprehensive worldwide report65 compiled by World 
Cancer Research Fund and American Institute for Cancer 
Research indicated a significant relation between lifestyle, 
including food consumption, and cancer prevention. While 
recognizing the limitations and lack of rigorous scientific 
validation of many dietary studies as well as the need 
for more and better research, there are some interesting 
  observations that deserve particular attention. In general, 
the following dietary elements have been linked with cancer 
risk:68 Aflatoxins in foods causes liver cancer, Chinese-style 
salted fish increases the risk for nasopharyngeal cancer, 
preserved meat and red meat may increase the risk for col-
orectal   cancer, salt-preserved foods and high salt intake may 
increase the risk for stomach cancer, and very hot drinks and 
foods may increase the risk for cancers of the oral cavity, 
pharynx, and esophagus. High-fat diets have been associ-
ated with an increase in the risk of cancers of the colon 
and   rectum, prostate, and endometrium.62 The association 
between   high-fat diets and breast cancer is much weaker. 
Also excessive intake of sugar and other highly refined car-
bohydrates may contribute to insulin insensitivity, alterations 
in the amount and distribution of body fat, and increased 
concentrations of growth factors that may promote the growth 
of cancers.62 On the other hand, many dietary factors have 
been reported to have some protective values for cancer 
  prevention. Vegetables and fruits contain specific phy-
tochemicals, such as carotenoids, flavonoids, terpenes, ste-
rols, indoles, and phenols, which may have protective effects 
against certain cancers.62 Garlic, used for flavoring in cooking 
is unique because of its high sulfur content. Increased intake 
of garlic has been associated with decreased risk of colorectal International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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cancer,71 stomach cancer72 and a 50% reduction in prostate 
cancer risk.73 The health benefits of the allium compounds 
contained in garlic and other   vegetables in the onion family 
have been publicized widely, but insufficient evidence exists 
at this point to support a specific role for this vegetable in 
cancer prevention. Cruciferous vegetables including broccoli, 
cauliflower, cabbage, Brussels sprouts, bokchoy, and kale 
include several components that have been highlighted to 
lower cancer risk. These include glucosinolates, crambene, 
indole-3-carbinol, and, especially, isothiocyanates which are 
derived from glucosinolates.74–76 Several laboratory studies 
have suggested that cruciferous vegetables help regulate 
a complex system of bodily enzymes that defend against 
cancer. Components of these vegetables have shown the 
ability to stop the growth of cancer cells in various tissue and 
animal models, including tumors of the breast and colon.75,76 
Epidemiologic studies have also suggested an inverse cor-
relation between consumption of cruciferous vegetables and 
the risk of many cancers including the risk of lung, stom-
ach, colorectal, bladder, and other cancers.74–76 The relation 
between cruciferous vegetable intake and breast cancer risk 
has also been suggested in epidemiological studies but is 
less clear.77
Vitamins and supplements
Despite becoming a growing field in health care mainly 
because of consumers’ interest and affordability,   conflicting 
literature exists on the benefit of many vitamins and 
nutritional supplements, especially in association with   cancer 
prevention.81–104 Our experience has been that healthy con-
sumers as well as cancer patients seek vitamins and dietary 
supplements to boost their immune system, improve their 
quality of life, prevent occurrence or   recurrence of cancer, and 
obtain many other benefits despite the absence of scientific 
evidence and even potential toxicity in some instances.81 
Some reports such as the unproven “triage theory”82–84 have 
suggested a rationale for a causal link between chronic modest 
deficiency of micronutrients (essential minerals,   vitamins, 
amino acids, and fatty acids) and the many degenerative 
diseases accompanying aging such as cancer, immune 
dysfunction, cognitive decline,   cardiovascular disease, and 
stroke. Micronutrient deficiencies are common. For example, 
over half of the US population have inadequate intakes of 
magnesium,84 almost all African-Americans are extremely 
low in vitamin D,85 and much of the population is low in 
a variety of other micronutrients (eg, omega-3 fatty acids, 
potassium, calcium, vitamin C, vitamin E, vitamin K).82,86 
No overt pathologies have been associated with marginal to 
moderate levels of deficiency, yet it has been suggested that 
pathology can be insidious.84   Unfortunately, as noted above 
there are significant   limitations to experimental approaches 
available for demonstrating a causal relation between micro-
nutrient deficiency and cancer.87,88 A   critical analysis of this 
large literature is beyond the scope of this manuscript, but 
owing to recent public debate related to vitamin D, we will 
review here the existing literature on vitamin D and can-
cer. A recent report from the Institute of Medicine89   concluded 
that the prevalence of vitamin D inadequacy in North America 
has been overestimated. It identified further research and 
clinical priorities, including reassessment of laboratory 
ranges for 25-hydroxy vitamin D, to avoid problems of both 
under- and over treatment.
Vitamin D and cancer
Two major forms of vitamin D are important to humans: 
vitamin D2, or ergocalciferol, and vitamin D3, or cholecal-
ciferol. Vitamin D2 is made naturally by plants, and vitamin 
D3 is made naturally by the body when the skin is exposed 
to ultraviolet radiation (in particular UVB radiation) in sun-
light. Vitamin D2 and vitamin D3 can also be commercially 
manufactured.90 Dietary sources rich in vitamin D include 
fatty fish, fish liver oil, eggs, meat, cheese, and fortified foods, 
such as milk, juices, yogurt, bread, and breakfast cereals.90
A possible role for vitamin D in cancer prevention has 
been investigated somewhat extensively but the evidence of 
potential benefit is limited and inconsistent.91–100 There are 
no current recommendations to use vitamin D supplements 
to reduce the risk of any type of cancer. We here review 
some of the data that sparked some debate about the use of 
vitamin D for cancer prevention. Large randomized clinical 
trials investigating the effects of vitamin D intake on bone 
health have suggested that higher vitamin D intake may 
reduce the risk of cancer.91 A study involving nearly 1200 
healthy postmenopausal women who took daily supplements 
of calcium (1400 mg or 1500 mg) and vitamin D (25 µg 
vitamin D, or 1100 IU – a relatively large dose) or a placebo 
for 4 years found that women who took the supplements had 
a 60% lower overall incidence of cancer;91 however, the study 
did not include a vitamin D-only group. Two cohort studies, 
the Nurses’ Health Study, and the Health Professionals 
Follow-Up Study, have shown an inverse association between 
plasma vitamin D levels and colorectal cancer.92 Vitamin D 
metabolites help maintain a normal calcium gradient in the 
colon epithelial crypts92 and high serum levels of 25(OH)D 
are associated with markedly decreased proliferation of 
noncancerous but high-risk epithelial cells in the colon.93 International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
282
Nahleh et al
In another study, the vitamin D intakes of 3000 people from 
several Veterans Affairs medical centers were examined to 
determine whether there was an association between intake 
and advanced colorectal neoplasia.94 Individuals with the 
highest vitamin D intakes (.16 µg, or 645 IU, per day) had 
a lower risk of developing advanced neoplasia than those 
with lower intakes.94 Other reports also suggest an inverse 
association between vitamin D levels and risk of death due 
to colorectal cancer.95,96 However, data on the association 
between vitamin D and breast cancer risk are conflicting. 
In the Women’s Health Initiative, calcium plus vitamin D 
supplementation for an average of 7 years did not reduce the 
incidence of invasive breast cancer compared with placebo.97 
However, other observational studies reported that intake 
of 2000 IU/day of vitamin D3, and, when possible, very 
moderate exposure to sunlight, could raise serum 25(OH) 
D to 52 ng/mL, a level associated with reduction by 50% in 
incidence of breast cancer.98 Similarly, epidemiological stud-
ies have yielded inconsistent associations between   vitamin D 
status and other cancers, like pancreatic and prostate cancer. 
Some studies even suggest that there may be an increased 
risk of prostate cancer associated with increased serum 
25-hydroxyvitamin D [25(OH)] or vitamin D levels.99 In 
contrast, other prospective cohort studies have shown that 
higher 25(OH) D score was associated with a lower risk of 
pancreatic cancer.100
Alcohol
Most people recognize that heavy alcohol use can cause 
health problems but many people may not be aware that 
alcohol use can increase cancer risk. A causal association 
has been suggested between alcohol consumption and 
many cancers, including cancers of the oral cavity, pharynx, 
larynx, esophagus, liver, colon, rectum, breast cancer, and 
lung cancer.105–107 In women, alcohol consumption has been 
established as a risk factor for breast cancer and may also 
increase risk of breast cancer recurrence, particularly among 
postmenopausal and overweight and obese women.108 The 
combined use of alcohol and tobacco increases the risk of 
these cancers far more than the effects of either drinking or 
smoking alone.109 This is of significant importance especially 
in countries such as the US, where it is estimated that 52% 
of adults are current regular drinkers, consuming at least 
12 drinks per year.109
The exact mechanism by which alcohol affects cancer risk 
is not completely understood but there are several suggested 
potential factors. Alcohol may act as an irritant, especially in 
the mouth and throat. Cells that are damaged may develop 
DNA changes that can be a precursor of cancer.105 Alcohol 
may also act as a solvent, helping other harmful chemicals, 
such as those found in tobacco smoke, to enter the cells 
lining the upper digestive tract more easily; this may help 
explain why the combination of smoking and drinking is 
much more likely to cause cancers in the mouth or throat 
than either smoking or drinking alone.109 Another mechanism 
focuses on acetaldehyde, a suspected carcinogen that is the 
first metabolite formed as the body breaks down alcohol. 
Recent reports indicate that polyamines, natural compounds 
involved in cell growth, interact with acetaldehyde and 
trigger reactions that damage DNA, a situation that can lead 
to the developmentof cancer.105,110 Polyamines cause the 
conversion of acetaldehyde into crotonaldehyde, an environ-
mental pollutant known to cause cancer in animals.110,111
Cancer chemoprevention research
There have been numerous attempts to use chemopreven-
tion for decreasing the risk of certain cancers. The selective 
estrogen-receptor modulator (SERM) tamoxifen became 
the first US Food and Drug Administration (FDA)-approved 
agent for reducing breast cancer risk, but did not gain wide 
acceptance for prevention, largely because it increased 
endometrial cancer and thromboembolic events.112 The FDA 
subsequently approved the SERM raloxifene for breast cancer 
risk reduction following its demonstrated effectiveness in 
preventing invasive breast cancer in the Study of Tamoxifen 
and Raloxifene. Raloxifene caused less toxicity (versus 
tamoxifen), including reduced thromboembolic events and 
endometrial cancer.112 The FDA also approved the use of 
a vaccine (Cervarix®; GlaxoSmithKline, London, UK) for 
use in girls and women ages 10 years through 25 years to 
prevent cervical cancer and precancerous lesions caused by 
human papillomavirus types 16 and 18, and most recently 
the quadrivalent human papillomavirus (types 6, 11, 16, 
18) recombinant vaccine (Gardasil®; Merck & Co., Inc, 
Whitehouse Station, NJ) to prevent anal cancer in men and 
women aged 9 through 26 years.113 Prevention of prostate can-
cer has also received significant attention. However, the FDA 
denied approval of two initially promising 5-alpha reductase 
inhibitors dutasteride and finasteride for the prevention of 
prostate cancer following the results of two large random-
ized trials Prostate Cancer Prevention Trial and Reduction 
by Dutasteride of Prostate Cancer Events, citing possible 
links to heightened incidence of high-grade tumors. This 
remains, however, somewhat controversial.114 Efforts to use 
isolated vitamins and nutrients have proved less successful. 
The Selenium and Vitamin E Cancer Prevention Trial and International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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the Physician’s Health Study II showed negative results for 
vitamin E, vitamin C, and selenium supplementation on 
decreasing prostate cancer risk.114
Cancer prevention based on dietary and lifestyle 
interventions remains a hot research topic. However, 
  inconsistencies and conflicting information call for further 
rigorous research trial designs possibly focusing on high-
risk populations identified through genomic and molecular 
research.
Summary and recommendations
1.  Smoking cessation: one could argue that the single most 
important behavioral modification that can be achieved 
toward minimizing personal cancer risk is to quit 
smoking. All types of tobacco products contain nicotine 
and cancer-causing substances. Both smokeless tobacco 
and smoking tobacco are known to cause cancers in 
humans and there is no known safe level of tobacco use.7 
People who use any type of tobacco product should be 
urged to quit. For those who use smoking tobacco, the risk 
of premature death and the chance of developing cancer 
depend on many factors, including the number of years 
a person smokes, the number of cigarettes smoked per 
day, the age at which smoking began, and the smokers’ 
symptoms at the time of quitting.7–10 However, people 
who quit smoking, regardless of their age, are less likely 
than those who continue to smoke to die from smoking-
related illness. Prevention and cessation among youth 
cannot be overemphasized. Also, among people who have 
already developed cancer, quitting smoking reduces the 
risk of developing a second cancer.9
2.  Preventing weight gain and maintaining a healthy 
weight: this approach can potentially reduce the risk 
of many cancers. Overweight status and obesity are 
associated with increased risk of cancers at several 
sites.12–17 These findings are supported by both clinical 
as well as epidemiological studies. Overweight and 
obese individuals have more adipose tissues, which 
can produce hormones such as insulin or estrogen that 
could promote carcinogenic mechanisms. Obesity may 
account for a third of   several major cancers – colon, 
breast (postmenopausal),   endometrial, kidney, and cancer 
of the esophagus. Obesity is becoming epidemic in the 
US and the trend is very worrisome. Experts recom-
mend that people establish habits of healthy eating early 
in life to prevent weight gain and obesity.15 Individuals 
who are already overweight or obese are advised to 
avoid additional weight gain, and to lose weight through 
balancing caloric intake with physical activity, choosing 
foods low in calories, and avoiding large portion sizes. 
Even a weight loss of only 5% to 10% of total weight has 
been suggested to provide significant health benefits.15
3.  Physical activity: scientific evidence indicates that 
physical activity may reduce the risk of several types of 
cancer, including cancers of the breast and colon, and can 
provide other important health benefits. Physical activity 
acts in a variety of ways to impact cancer risk. Regular 
physical activity helps maintain a healthy body weight by 
balancing caloric intake with energy expenditure. It also 
helps to minimize the negative association between 
lack of physical activity and cancer, including changes 
in endogenous sexual and metabolic hormone levels 
and growth factors, and to decrease obesity and central 
adiposity and possibly changes in immune function. 
The general recommendation according to the American 
cancer Society62 is for adults to undertake a minimum 
of 30 minutes of at least moderate intensity physical 
activity on at least 5 days a week. Previously sedentary 
men over age 40 years, women over age 50 years, adults 
with chronic disease, or risk factor for cardiovascular 
disease should consult their health care provider before 
starting a regular exercise program. Cancer patients 
should ask their doctors about an appropriate physical 
activity program.
4.  Diet: evidence suggests a strong association between 
dietary factors and cancer and supports the beneficial 
effects of implementing dietary changes like increasing 
fruit and vegetable consumption. Major national efforts 
to help improve food related behavior, such as the “5-A 
Day for Better Health Program”78 have been launched 
since the 1980s and resulted in improved consumers’ 
awareness.79,80 Further adherence to the American   Cancer 
Society recommendations for healthy diet62 would 
constitute another step in the right direction. These 
include: 1) eating five or more servings of   vegetables 
and fruits each day. The best way to eat   vegetables 
and fruit is the natural way, without processing and 
not in the form of pills; 2) choosing whole grains (eg, 
rice, bread, pasta, and cereals made of wheat, oats, and 
barley) over processed refined grains and sugars such 
as pastries, sweetened cereals, and other high-sugar 
foods; 3) limiting intake of processed meats and red 
meats especially those with high fat (eg, fish, poultry, 
or beans instead of beef, pork, and lamb or using lean 
cuts and small portions). It is recommended to prepare 
meat by baking, broiling, or poaching rather than by International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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frying or charbroiling and to substitute vegetable oils for 
butter or lard; and 4) choosing foods that help maintain 
a healthful weight.
5.  Vitamins and supplements: consumers are greatly interested 
in the incidence of disease reduction by an inexpensive 
micronutrient intervention. The few interventions and 
clinical trials done in human populations designed to 
test whether supplements can reduce cancer risk have 
yielded disappointing and conflicting results.91,101 Many 
studies using high doses of single nutrients have shown 
no benefit and have even shown potential harm.99,102–104 
Consequently, there are currently no   consistent recom-
mendations for the use of supplements and vitamins in 
the general population for cancer prevention. Food is 
the best source of vitamins and minerals and there is 
good evidence that a diet rich in vegetables, fruits, and 
other plant-based foods may reduce the risk of cancer 
as noted above, but there is no evidence at this time that 
supplements can reduce cancer risk. Future and ongo-
ing research should provide a better guidance in the 
association between specific supplements and vitamins 
such as vitamin D and specific cancer risk. Although 
people obtain some vitamin D from dietary sources, most 
  vitamin D is made in the body after the skin is exposed to 
sunlight. Despite the known and potential health benefits 
of vitamin D, increasing sun exposure may, however, 
increase the risk of skin cancer and caution should be 
exercised by using sun protection when UV levels are 
moderate or higher.89
6.  Alcohol: alcohol consumption has been linked to 
the increased risk of many cancers. The American 
Cancer Society recommends that people who drink 
alcohol limit their intake to no more than two drinks 
per day for men and one drink a day for women.62 
The recommended limit is lower for women because 
of their smaller body size and their metabolism. The 
American Cancer   Society recognizes that while alcohol 
use has been linked to   several types of cancer and other 
health risks, this is complicated by the fact that low to 
moderate alcohol intake may be linked with decreased 
risk of heart disease. In view of the potential cancer 
risk involved, however, this should not be a reason for 
adults who currently do not drink alcohol to start, as 
there are many other ways of reducing heart disease 
risk, including avoiding smoking, eating a diet low in 
saturated and trans fats, maintaining a healthy weight, 
staying physically active on a regular basis, and control-
ling blood pressure and cholesterol.62
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